Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for early post-treatment breast cancer survivors

Sohl, Stephanie J.; Levine, Beverly; Avis, Nancy E.

doi:10.1037/e546872013-012

Cited by 3 publications

(3 citation statements)

References 30 publications

(34 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Estos han sido destacados en diversas publicaciones como importantes secuelas que presentan las pacientes a largo plazo 7,14,[20][21][22][23][24][25][26][27][28][29][30] . Los estudios sobre fatiga relacionada al cáncer reportan una etiología incierta, aunque se postula un origen multifactorial, combinando condiciones derivadas de la patología y sus tratamientos, alteraciones psicológicas (depresión, ansiedad, cognitivas), y otras desregulaciones del sistema inmune [22][23][24] .…”

Section: Discussionunclassified

Calidad de vida en pacientes chilenas sobrevivientes de cáncer de mama

Irarrázaval¹,

Kleinman²,

R³

et al. 2016

Rev. méd. Chile

View full text Add to dashboard Cite

show abstract

Section: Discussionunclassified

Calidad de vida en pacientes chilenas sobrevivientes de cáncer de mama

Irarrázaval¹,

Kleinman²,

R³

et al. 2016

Rev. méd. Chile

View full text Add to dashboard Cite

show abstract

“…QLACS has a high correlation with the SF36 questionnaire and the FACT-6 -Functional Assessment of Cancer Therapy [12]. QLACS is an instrument with established internal consistency (Cronbach's alpha 0.72) [12,13]. The questionnaire consists of 47 closed items.…”

Section: Methodsmentioning

confidence: 99%

The quality of life of hospitalized and outpatient oncological patients

Dobríková

Stachurová

Slaná

et al. 2018

Kontakt

View full text Add to dashboard Cite

The quality of life of sufferers of chronic and serious diseases is a phenomenon which has come to the attention of contemporary medicine, nursing and other supporting professionals working with cancer patients. This research set out to determine whether there is a difference in the self-perception of the quality of life of hospitalized cancer patients and cancer outpatients. This study deals with the comparison of quality of life in 128 outpatient and hospitalized cancer patients in the curative stage of cancer. The QLACS (Quality of Life in Adult Cancer Survivors) "How do I live with the disease?" questionnaire was used in the survey. To ascertain the total value of the quality of life we used scoring with a potential spread of responses from 1 to 7 in the QLACS questionnaire. Using this scale, various items in the questionnaire measured the level of each frequency of problems (1 = never, 7 = always). The resulting value of quality of life of the patient was higher when the final score was lower. A significance level of 0.005 in the resulting value of quality of life (sig. = 0.000) in the study group of patients confirmed the hypothesis, which assumed that the quality of life of hospitalized cancer patients is significantly lower than the quality of life of cancer outpatients. The quality of life of hospitalized cancer patients is significantly lower than the quality of life of cancer outpatients (sig. = 0.000) since admission to hospital with all the accompanying negative factors for the patient-the separation from family and loved ones, unfamiliar environment, undergoing often difficult and invasive diagnostic or therapeutic procedures, which amongst others, are very stressful for the patient, with a potentially negative impact on the patient's quality of life.

show abstract

“…In a cross-sectional study, Avis et al evaluated the psychometric properties of QLACS in a sample of 94 long-term breast cancer survivors [38]. While the QLACS was originally developed for long-term (5 years) cancer survivors, a more recent study has also evaluated its use in a sample of 552 breast cancer survivors 18-24 months post-diagnosis [39].…”

Section: Additional Validated Patient-reported Outcomes Instruments Fmentioning

confidence: 99%

Patient-reported outcomes in cancer survivorship

Gordon

Chen

2017

Acta Oncologica

View full text Add to dashboard Cite

Background: There are currently 33 million cancer survivors worldwide. With improvements in early cancer detection and treatments, patients are living longer -and it is well-recognized that many survivors develop short-and long-term physical, psychosocial and spiritual effects as a result of their diagnoses and treatments. There is increasing awareness of the importance of using patient-reported outcomes (PROs) to accurately assess these effects in cancer survivors. Validated patient-reported outcome instruments: Traditionally, physicians have assessed the acute and late side effects of cancer treatments with standardized scales such as the CTCAE. However, multiple studies have demonstrated that PROs more accurately capture patient symptoms than physician assessment. In this article we describe frequently used, validated, general and cancer-specific PRO instruments that assess symptoms. We describe additional PRO instruments that assess unmet needs, interpersonal relationship issues, and psychosocial and financial problems. Published studies using these instruments have identified issues commonly faced by cancer survivors worldwide. Discussion and summary: While PROs are increasingly used in research, further efforts are needed to integrate PRO assessment into routine clinical care, so that timely and accurate assessments can translate into better management of issues -ultimately improving the lives of cancer survivors.

show abstract

Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for early post-treatment breast cancer survivors

Cited by 3 publications

References 30 publications

Calidad de vida en pacientes chilenas sobrevivientes de cáncer de mama

Calidad de vida en pacientes chilenas sobrevivientes de cáncer de mama

The quality of life of hospitalized and outpatient oncological patients

Patient-reported outcomes in cancer survivorship

Contact Info

Product

Resources

About